Likely active: portfolio news Jul 2026 Verified 4 Nov 2026
Epidarex Capital
Transatlantic life-science venture firm providing seed and Series A capital to start-ups and university spin-outs in under-ventured research hubs in the UK and US, across therapeutics, medical devices and health tech.
- Type
- VC firm
- Location
- Edinburgh, United Kingdom
- Stages
- Seed, Series A
- Backs
- Biotech and pharma, Medtech and digital health
- Sectors
- Biotech, Healthtech and life sciences
- Fund size / AUM
- $16.9M gross private fund assets (Form ADV; private funds: 3, of which venture capital: 3)
- Portfolio mix
- Biotech and pharma 84%; Medtech and digital health 16% (n=25)
- Website
- epidarex.com
Contacts on file
For Epidarex Capital, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); how to pitch (the route the firm publishes); LinkedIn page.
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
Apellis PharmaceuticalsNodTheraMacomicsRapidPulseHarpoon Medical
Sources
- epidarex.com/
- epidarex.com/about-us/
- epidarex.com/strategy/
- epidarex.com/contact-us/
- epidarex.com/portfolio/
- adviserinfo.sec.gov/firm/summary/307874
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 18 lists
Medtech investors in the UK (58)Biotech investors in the UK (92)Series A medtech investors (125)Series A biotech investors (153)Series A investors in the UK (154)Venture capital firms in the UK (192)Healthtech investors in the UK (194)Seed medtech investors (278)Seed investors in the UK (295)Seed biotech investors (300)Series A healthtech investors (401)Startup investors in the UK (416)Medtech investors (457)Biotech investors (484)Seed healthtech investors (800)Series A investors (864)Healthtech investors (1,207)Seed investors (1,892)